Article Details
Retrieved on: 2022-12-02 16:09:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Nearly a third of patients develop immune response against FVIII replacement. Replacement therapy is a mainstay treatment for hemophilia A. It works ...
Article found on: hemophilianewstoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here